ClinicalTrials.gg
TerminatedNCT02565199Updated Oct 27, 2026Results posted

Premotor Cortex: A New Target for Stroke Motor Rehabilitation

An interventional study of rTMS Over Contralateral Hemisphere of Premotor Cortex and rTMS Over Ipsilateral Hemisphere of Premotor Cortex in Stroke, sponsored by Emory University. Terminated at 1 site in United States. Open to participants aged 55 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-27.

Sponsored by Emory University · Not applicable, Interventional, and Basic science

How we know

Why this study was terminated
Study was suspended pending additional funding to continue participant recruitment and was ultimately terminated in 2024.
Updated Oct 27, 2026Now TerminatedResults posted+8 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
11
Allocation
Randomized
Ages
55 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 23 studies in Stroke by Emory University — 4 open to participants now, 4 under way, none of them phase 3. Stroke · Emory University.

Enrollment
20th of 23
11 · median 32
Started
2016
with 1 other
No phase
17 of 23
4 open now
Registered
11th of 23
by date

Among the 23 studies in Stroke by Emory University, this one is the 20th largest by enrollment, is one of 2 that started in 2016, is one of 17 with no phase, and was the 11th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

4 of the 23 studies in Stroke by Emory University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 55 Years to 80 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 23 studies in Stroke by Emory University, or all of them as a file.
02

Study summary

The goal of the study is to determine the effect of repetitive transcranial magnetic stimulation (rTMS) over the premotor cortex on training-related improvements in motor performance and associated neural plasticity.

Read the detailed description

Occlusion of the middle cerebral artery is the most common cause of stroke. Because the middle cerebral artery supplies blood to the motor cortices, middle cerebral artery stroke often impacts the integrity of the motor cortex and its associated corticospinal projections. Consequently, the majority of the 6.8 million people who have suffered a stroke in the United States experience hemiparesis as a result of the infarct. Although stroke survivors are encouraged to participate in rehabilitation programs, less than half of all individuals post-stroke regain complete motor function. Because motor deficits, especially of the upper extremities, can dampen the quality of life, there is an urgent need to improve current rehabilitation programs to allow more stroke survivors to achieve higher functional gains.

Motor training is an important part of recovery after stroke. During motor training, stroke patients practice performing a movement and become better at performing the trained movement over time. Repetitive transcranial magnetic stimulation (rTMS), which uses magnetism to excite neurons near the surface of the brain, may further improve performance. Healthy adults made larger training-related improvements in their motor performance when they received rTMS over the primary motor cortex during motor training. There is evidence that the premotor cortex may be a more effective target than the primary motor cortex for rTMS for some stroke survivors. In the current study, the investigator will determine the effect of rTMS over the premotor cortex on training-related improvements in motor performance in healthy adults.

In this study the researchers will evaluate the effect of premotor cortex (PMC) rTMS on motor learning with a double-blind randomized study consisting of five experiments separated by at least 72 hours. During each experiment, participants complete motor training while receiving one of five rTMS protocols. All participants will receive each rTMS protocol once. The order of the rTMS protocols will be randomized and counterbalanced prior to recruitment. The researchers will evaluate the effect of each rTMS protocol on training-related motor learning by collecting kinematic and neurophysiological measurements before (pre-training), immediately post-training, and 60 minutes post-training.

03

Conditions studied

  • Stroke

Browse trials for

Keywords

  • Transcranial Magnetic Stimulation
  • Hemiparesis
  • Post-stroke rehabilitation
04

Who can participate

The criteria were revised on the registry on Oct 27, 2026. See what changed

Ages eligible
55 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Have the ability to give informed, written consent
  • Be aged 55-80 years old
  • Be right-handed using the Edinburgh handedness inventory
  • Have intact cognitive abilities, determined by a score higher than the 75th percentile on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)
  • No current depression, determined by a score less than a 7 on the Hamilton Depression Rating Scale (HDRS)
  • No neurological disease
  • No contradictions to Transcranial Magnetic Stimulation (TMS)
  • TMS over the extensor carpi ulnaris (ECU) hotspot must be able to evoke a motor evoked potential (MEP) in the ECU muscle
  • MEP amplitude must increase by at least 20% as the TMS intensity increases
  • Comfortable when receiving TMS of all strengths

Exclusion criteria

Exclusion Criteria:

  • Impaired cognitive abilities, determined by a score less than the 75th percentile on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)
  • Current depression, determined by a score of more than 7 on the Hamilton Depression Rating Scale (HDRS)
  • Neurological disease
  • Has a contradiction to TMS
  • MEP cannot be evoked with TMS in the ECU muscle
  • Inability to tolerate one or more TMS strengths
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Investigator)
Enrollment
11 participants (actual)

Study arms

  • Experimental
    Repetitive TMS During Motor Training

    Healthy, right-handed participants complete five testing sessions. During each testing session, participants complete motor training while receiving one of five repetitive transcranial magnetic stimulation (rTMS) protocols. Participants receive a different rTMS protocol at each testing session so that they receive all rTMS protocols by the end of the study.

    Device: rTMS Over Contralateral Hemisphere of Premotor Cortex · Device: rTMS Over Ipsilateral Hemisphere of Premotor Cortex · Device: Control 1: rTMS Timed 400 ms After Movement-related EMG · Device: Control 2: rTMS Over the Somatosensory Cortex · Device: Control 3: Sham rTMS · Other: Motor Training

Interventions

  • DevicerTMS Over Contralateral Hemisphere of Premotor Cortex

    This intervention uses rTMS located over the premotor cortex of the contralateral hemisphere (opposite side of the body) to the training wrist. For this intervention the rTMS occurs at a frequency of 0.1 Hz, 50 milliseconds (ms) before the onset of movement-related electromyography (EMG). The MagStim Super Rapid 2 Transcranial Magnetic Stimulator is used.

    Also known as: MagStim Super Rapid 2 Transcranial Magnetic Stimulator

  • DevicerTMS Over Ipsilateral Hemisphere of Premotor Cortex

    This intervention uses rTMS located over the premotor cortex of the ipsilateral hemisphere (the same side of the body) to the training wrist. For this intervention the rTMS occurs at a frequency of 0.1 Hz, 50 milliseconds (ms) before the onset of movement-related EMG. The MagStim Super Rapid 2 Transcranial Magnetic Stimulator is used.

    Also known as: MagStim Super Rapid 2 Transcranial Magnetic Stimulator

  • DeviceControl 1: rTMS Timed 400 ms After Movement-related EMG

    Control condition 1 uses rTMS over the premotor cortex of the contralateral hemisphere to the training wrist, with a frequency of 0.1 Hz. The rTMS occurs 400 milliseconds (ms) after the onset of movement-related EMG and uses the MagStim Super Rapid 2 Transcranial Magnetic Stimulator.

    Also known as: MagStim Super Rapid 2 Transcranial Magnetic Stimulator

  • DeviceControl 2: rTMS Over the Somatosensory Cortex

    This intervention uses rTMS located over the somatosensory cortex of the contralateral hemisphere to the training wrist. For this intervention the rTMS occurs at a frequency of 0.1 Hz, 50 milliseconds (ms) before the onset of movement-related EMG. The MagStim Super Rapid 2 Transcranial Magnetic Stimulator is used.

    Also known as: MagStim Super Rapid 2 Transcranial Magnetic Stimulator

  • DeviceControl 3: Sham rTMS

    Control condition 3 uses rTMS located over the premotor cortex of the contralateral hemisphere to the training wrist, at a frequency of 0.1 Hz, 50 milliseconds (ms) before the onset of movement-related EMG. The MagStim Super Rapid 2 Transcranial Magnetic Stimulator with the sham coil is used.

    Also known as: MagStim Super Rapid 2 Transcranial Magnetic Stimulator with Sham Coil

  • OtherMotor Training

    During motor training, participants will quickly extend their hand at a pace of one extension every 5 seconds (0.2Hz) in response to an auditory cue.

06

What researchers measure

Primary outcomes

  1. Change in Primary Motor Cortex (M1) Excitability Derived From Stimulus Response Curve (SRC)

    Functional organization of ipsilateral M1 is assessed by changes in area under the curve of stimulus response curves over the hotspots of an agonist (extensor carpi ulnaris (ECU)) muscle of the training movement. The area under the curve (AUC) was calculated by summing the mean motor evoked potential (MEP) amplitudes per intensity and subject evoked by TMS at intensities 25 -80% maximum stimulator output (MSO), in increments of 5% MSO. The area under the stimulus response curve is normalized to the pre-training measurement.

    Time frame: Baseline/Pre-training, Immediately Post-training, 60 Minutes Post-training during each of 5 study visits (up to 217 days)

Secondary outcomes

  1. Change in Mean Reaction Time

    Participants are asked to perform 7 auditory-cued ballistic wrist extensions before and after motor training. Electromyographic (EMG) activity recorded during the ballistic wrist extensions is used to measure reaction time. Reaction time is the length of time between the auditory cue and the onset of the movement-related EMG burst of the extensor carpi ulnaris (ECU) muscle. The change in reaction time from baseline is calculated as the post-training score minus the baseline score.

    Time frame: Baseline/Pre-training, Immediately Post-training, 60 Minutes Post-training during each of 5 study visits (up to 217 days)

  2. Change in Mean Peak Velocity

    Peak velocity of wrist movement from 6 auditory-paced ballistic wrist extension was collected using a gyrometer. Peak velocity is an assessment of hand motor kinematics. Velocity measures speed in a particular direction of motion.

    Time frame: Baseline/Pre-training, Immediately Post-training, 60 Minutes Post-training during each of 5 study visits (up to 217 days)

07

Results

Posted Oct 27, 2026

Participant flow

Participant enrollment began July 7, 2016 and all study visits were completed by November 10, 2019. Participants were enrolled at Emory University in Atlanta, Georgia, USA. The study was suspended for several years and was ultimately terminated in 2024.

Participant flow — Overall Study
MilestoneRepetitive TMS During Motor Training
Started11
Rtms over contralateral hemisphere of premotor cortex11
Rtms over ipsilateral hemisphere of premotor cortex11
Control 1: rtms timed 400 ms after movement-related emg11
Control 2: rtms over the somatosensory cortex11
Control 3: sham rtms11
Completed11
Not completed0

Outcome measures

PrimaryChange in Primary Motor Cortex (M1) Excitability Derived From Stimulus Response Curve (SRC)

Functional organization of ipsilateral M1 is assessed by changes in area under the curve of stimulus response curves over the hotspots of an agonist (extensor carpi ulnaris (ECU)) muscle of the training movement. The area under the curve (AUC) was calculated by summing the mean motor evoked potential (MEP) amplitudes per intensity and subject evoked by TMS at intensities 25 -80% maximum stimulator output (MSO), in increments of 5% MSO. The area under the stimulus response curve is normalized to the pre-training measurement.

Time frame:
Baseline/Pre-training, Immediately Post-training, 60 Minutes Post-training during each of 5 study visits (up to 217 days)
Reported as:
Mean · ratio of pre/post MEP amplitudes
Change in Primary Motor Cortex (M1) Excitability Derived From Stimulus Response Curve (SRC)
ratio of pre/post MEP amplitudesrTMS Over the Premotor Cortex of the Contralateral HemisphererTMS Over the Premotor Cortex of the Ipsilateral HemisphereControl 1: rTMS Over the Premotor Cortex of the Contralateral Hemisphere +400msControl 2: rTMS Over the Somatosensory Cortex of the Contralateral HemisphereControl 3: Sham rTMS
Baseline to Immediately post-training0.50 ± 0.90.4 ± 0.60.30 ± 0.550.35 ± 0.600.30 ± 0.50
Baseline to 60 minutes post-training0.6 ± 1.20.7 ± 0.90.8 ± 0.750.2 ± 0.50.35 ± 0.36
SecondaryChange in Mean Reaction Time

Participants are asked to perform 7 auditory-cued ballistic wrist extensions before and after motor training. Electromyographic (EMG) activity recorded during the ballistic wrist extensions is used to measure reaction time. Reaction time is the length of time between the auditory cue and the onset of the movement-related EMG burst of the extensor carpi ulnaris (ECU) muscle. The change in reaction time from baseline is calculated as the post-training score minus the baseline score.

Time frame:
Baseline/Pre-training, Immediately Post-training, 60 Minutes Post-training during each of 5 study visits (up to 217 days)
Reported as:
Mean · milliseconds
Change in Mean Reaction Time
millisecondsrTMS Over the Premotor Cortex of the Contralateral HemisphererTMS Over the Premotor Cortex of the Ipsilateral HemisphereControl 1: rTMS Over the Premotor Cortex of the Contralateral Hemisphere +400msControl 2: rTMS Over the Somatosensory Cortex of the Contralateral HemisphereControl 3: Sham rTMS
Immediately post-training minus pre-training-33 (-70 to 2)-18 (-40 to 8)13 (-10 to 36)-21 (-40 to 6)-29 (-30 to 5)
60 minutes post-training minus pre-training-40 (-80 to 0)-9 (-39 to 20)-2 (-25 to 21)-20 (-61 to 21)-24 (-52 to 4)
SecondaryChange in Mean Peak Velocity

Peak velocity of wrist movement from 6 auditory-paced ballistic wrist extension was collected using a gyrometer. Peak velocity is an assessment of hand motor kinematics. Velocity measures speed in a particular direction of motion.

Time frame:
Baseline/Pre-training, Immediately Post-training, 60 Minutes Post-training during each of 5 study visits (up to 217 days)
Reported as:
Mean · degrees per millisecond
Change in Mean Peak Velocity
degrees per millisecondrTMS Over the Premotor Cortex of the Contralateral HemisphererTMS Over the Premotor Cortex of the Ipsilateral HemisphereControl 1: rTMS Over the Premotor Cortex of the Contralateral Hemisphere +400msControl 2: rTMS Over the Somatosensory Cortex of the Contralateral HemisphereControl 3: Sham rTMS
Immediately post-training - Pre-training29 (-12.5 to 75)10 (-20 to 54)-13 (-77 to 49)90 (50 to 188)-28 (-88 to 29)
60 minutes post-training - Pre-training-20 (-76 to 38)-80 (-125 to 12)-25 (-95 to 49)24 (-20 to 68)-6 (-77 to 68)

Adverse events

Collected over Information on adverse events was collected during the each rTMS session, beginning at the first study visit and ending after the fifth study visit (up to 217 days).. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
rTMS Over the Premotor Cortex of the Contralateral Hemisphere0/11 (0%)0/11 (0%)0/11 (0%)
rTMS Over the Premotor Cortex of the Ipsilateral Hemisphere0/11 (0%)0/11 (0%)0/11 (0%)
Control 1: rTMS Over the Premotor Cortex of the Contralateral Hemisphere +400ms0/11 (0%)0/11 (0%)0/11 (0%)
Control 2: rTMS Over the Somatosensory Cortex of the Contralateral Hemisphere0/11 (0%)0/11 (0%)0/11 (0%)
Control 3: Sham rTMS0/11 (0%)0/11 (0%)0/11 (0%)

Baseline characteristics

The Baseline Analysis Population includes participants who contributed data to the analysis of the outcome measures. One participant was not included in data analyses due to technical reasons that caused the data to be unusable.

Age, Continuous
Age, Continuous(years)Repetitive TMS During Motor Training
Mean56.00 ± 5.73
Sex: Female, Male
Sex: Female, Male(Participants)Repetitive TMS During Motor Training
Female6
Male4
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Repetitive TMS During Motor Training
Region of Enrollment
Region of Enrollment(Participants)Repetitive TMS During Motor Training
United States10
08

Study locations

1 site
  • Emory University
    Atlanta, Georgia 30322, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Ran from Jul 2016 to primary completion in Nov 2019, 40 months.

Results were first posted in Oct 2026, 6 years 11 months after primary completion.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 27, 2026: start Sep 2015 → Jul 2016, primary completion Feb 2024 → Nov 2019 and completion Feb 2024 → Nov 2019.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 29, 2015
First posted
Oct 1, 2015
StartActual
Jul 7, 2016was Sep 2015
Primary completionActual
Nov 10, 2019was Feb 2024
CompletionActual
Nov 10, 2019was Feb 2024
Results first posted
Oct 27, 2026
Last update
Oct 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Suspended→Terminated Study was suspended pending additional funding to continue participant recruitment and was ultimately terminated in 2024.
changed Oct 27, 2026
Results
Results posted
posted Oct 27, 2026
Start date
Sep 2015→Jul 7, 2016 (actual)
Oct 27, 2026
Primary completion
Feb 2024→Nov 10, 2019 (actual)
Oct 27, 2026
Study completion
Feb 2024→Nov 10, 2019 (actual)
Oct 27, 2026
Enrollment
50 (estimated)→11 (actual)
Oct 27, 2026
Eligibility
Minimum age 18 Years→55 Years; 3 inclusion criteria edited, 12 removed; 2 exclusion criteria edited
What changed in the criteria
Inclusion criteria
  • RemovedMotor training only (pilot participants):
  • RemovedBe aged 18-80 years old
  • RemovedBe right-handed using the Edinburgh handedness inventory
  • RemovedHave intact cognitive abilities (score higher than 75th percentile on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS))
  • EditedHave intact cognitive abilities (, determined by a score higher than the 75th percentile on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS))
  • RemovedNo current depression (score less than 7 on the Hamilton Depression Rating Scale (HDRS))
  • EditedNo current depression (, determined by a score less than a 7 on the Hamilton Depression Rating Scale (HDRS))
  • RemovedNo neurological disease
  • RemovedNo contradictions to Transcranial Magnetic Stimulation (TMS)
  • RemovedTMS over the extensor carpi ulnaris (ECU) hotspot must evoke a motor evoked potential (MEP) in the ECU muscle
  • RemovedMEP amplitude must increase by at least 20% as the TMS intensity increases
  • RemovedThe subjects must be comfortable when receiving TMS of all strengths.
  • EditedThe subjects must be comfortableComfortable when receiving TMS of all strengths.
  • RemovedRemaining study participants:
  • RemovedHave the ability to give informed, written consent
Exclusion criteria
  • EditedImpaired cognitive abilities (, determined by a score lesserless than the 75th percentile on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS))
  • EditedCurrent depression (, determined by a score of more than 7 on the Hamilton Depression Rating Scale (HDRS))
Oct 27, 2026
Interventions
Added Device: rTMS Over Contralateral Hemisphere of Premotor Cortex·Device: rTMS Over Ipsilateral Hemisphere of Premotor Cortex·Device: Control 1: rTMS Timed 400 ms After Movement-related EMG·Device: Control 2: rTMS Over the Somatosensory Cortex·Device: Control 3: Sham rTMS; removed Device: rTMS over Premotor Cortex (Contralateral Hemisphere)·Device: rTMS over Premotor Cortex (Ipsilateral Hemisphere)·Device: rTMS (Control 1)·Device: rTMS (Control 2)·Device: rTMS (Control 3). Arms removed: Single motor training only
Oct 27, 2026
Primary outcomes
1 edited, 2 removed
What changed in the outcomes
  • EditedChange in stimulus response curvePrimary Motor Cortex (M1) Excitability Derived From Stimulus Response Curve (SRC)Time frame: Baseline, post-motor training (1 minute, 30 minutes and 60 minutes after completion of motor training) → Baseline/Pre-training, Immediately Post-training, 60 Minutes Post-training during each of 5 study visits (up to 217 days)
  • RemovedChange in wrist accelerationTime frame: Baseline, post-motor training (1 minute, 30 minutes and 60 minutes after completion of motor training)
  • RemovedChange in short interval intracortical inhibition (SICI)Time frame: Baseline, post-motor training (1 minute, 30 minutes and 60 minutes after completion of motor training)
Oct 27, 2026
Documents
Secondary outcomes
1 edited, 1 added, 2 removed
What changed in the outcomes
  • EditedChange in reaction timeMean Reaction TimeTime frame: Baseline and post-motor training (1 minute, 30 minutes and 60 minutes after completion of motor training) → Baseline/Pre-training, Immediately Post-training, 60 Minutes Post-training during each of 5 study visits (up to 217 days)
  • AddedChange in Mean Peak VelocityTime frame: Baseline/Pre-training, Immediately Post-training, 60 Minutes Post-training during each of 5 study visits (up to 217 days)
  • RemovedChange in wrist forceTime frame: Baseline, post-motor training (1 minute, 30 minutes and 60 minutes after completion of motor training)
  • RemovedChange in task accuracyTime frame: Baseline and post-motor training (1 minute after completion of motor training)
Oct 27, 2026
Show all 1 update
  1. Oct 27, 2026
    Suspended→Terminated
    Why stopped Study was suspended pending additional funding to continue participant recruitment and was ultimately terminated in 2024.
    Results posted
    Start date Sep 2015→Jul 7, 2016 (now actual)
    Primary completion Feb 2024→Nov 10, 2019 (now actual)
    Study completion Feb 2024→Nov 10, 2019 (now actual)
    Enrollment 50 (estimated)→11 (actual)
    Eligibility Minimum age 18 Years→55 Years; 3 inclusion criteria edited, 12 removed; 2 exclusion criteria edited
    What changed in the criteria
    Inclusion criteria
    • RemovedMotor training only (pilot participants):
    • RemovedBe aged 18-80 years old
    • RemovedBe right-handed using the Edinburgh handedness inventory
    • RemovedHave intact cognitive abilities (score higher than 75th percentile on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS))
    • EditedHave intact cognitive abilities (, determined by a score higher than the 75th percentile on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS))
    • RemovedNo current depression (score less than 7 on the Hamilton Depression Rating Scale (HDRS))
    • EditedNo current depression (, determined by a score less than a 7 on the Hamilton Depression Rating Scale (HDRS))
    • RemovedNo neurological disease
    • RemovedNo contradictions to Transcranial Magnetic Stimulation (TMS)
    • RemovedTMS over the extensor carpi ulnaris (ECU) hotspot must evoke a motor evoked potential (MEP) in the ECU muscle
    • RemovedMEP amplitude must increase by at least 20% as the TMS intensity increases
    • RemovedThe subjects must be comfortable when receiving TMS of all strengths.
    • EditedThe subjects must be comfortableComfortable when receiving TMS of all strengths.
    • RemovedRemaining study participants:
    • RemovedHave the ability to give informed, written consent
    Exclusion criteria
    • EditedImpaired cognitive abilities (, determined by a score lesserless than the 75th percentile on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS))
    • EditedCurrent depression (, determined by a score of more than 7 on the Hamilton Depression Rating Scale (HDRS))
    Primary outcomes 1 edited, 2 removed
    What changed in the outcomes
    • EditedChange in stimulus response curvePrimary Motor Cortex (M1) Excitability Derived From Stimulus Response Curve (SRC)Time frame: Baseline, post-motor training (1 minute, 30 minutes and 60 minutes after completion of motor training) → Baseline/Pre-training, Immediately Post-training, 60 Minutes Post-training during each of 5 study visits (up to 217 days)
    • RemovedChange in wrist accelerationTime frame: Baseline, post-motor training (1 minute, 30 minutes and 60 minutes after completion of motor training)
    • RemovedChange in short interval intracortical inhibition (SICI)Time frame: Baseline, post-motor training (1 minute, 30 minutes and 60 minutes after completion of motor training)
    Secondary outcomes 1 edited, 1 added, 2 removed
    What changed in the outcomes
    • EditedChange in reaction timeMean Reaction TimeTime frame: Baseline and post-motor training (1 minute, 30 minutes and 60 minutes after completion of motor training) → Baseline/Pre-training, Immediately Post-training, 60 Minutes Post-training during each of 5 study visits (up to 217 days)
    • AddedChange in Mean Peak VelocityTime frame: Baseline/Pre-training, Immediately Post-training, 60 Minutes Post-training during each of 5 study visits (up to 217 days)
    • RemovedChange in wrist forceTime frame: Baseline, post-motor training (1 minute, 30 minutes and 60 minutes after completion of motor training)
    • RemovedChange in task accuracyTime frame: Baseline and post-motor training (1 minute after completion of motor training)
    Interventions Added Device: rTMS Over Contralateral Hemisphere of Premotor Cortex·Device: rTMS Over Ipsilateral Hemisphere of Premotor Cortex·Device: Control 1: rTMS Timed 400 ms After Movement-related EMG·Device: Control 2: rTMS Over the Somatosensory Cortex·Device: Control 3: Sham rTMS; removed Device: rTMS over Premotor Cortex (Contralateral Hemisphere)·Device: rTMS over Premotor Cortex (Ipsilateral Hemisphere)·Device: rTMS (Control 1)·Device: rTMS (Control 2)·Device: rTMS (Control 3). Arms removed: Single motor training only
    + 9 other changes: verification date, responsible party, oversight details, description, conditions, design details, contact details, data sharing statement and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT02565199
Lead sponsor
Emory University
Collaborators
American Heart Association
Responsible party
Cathrin Buetefisch (Affiliate Scientist, Emory University) — Principal investigator
First posted
Oct 1, 2015
Start date
Jul 7, 2016
Primary completion
Nov 10, 2019
Completion
Nov 10, 2019
Results posted
Oct 27, 2026
Last update
Oct 27, 2026

Study contacts

Cathrin Buetefisch, MD, PhD
principal investigator · Emory University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion